Nobelpharma

NCT06940895

CollaboratorPhase 2Completed20255 people23 Apr 2025clinicaltrials.gov

NCT03972462

Phase 1Completed201912 people3 Jun 2019clinicaltrials.gov

NCT03765944

Phase 1Completed201810 people5 Dec 2018clinicaltrials.gov

NCT02757079

Phase 3Completed201699 people29 Apr 2016clinicaltrials.gov

NCT02757066

Phase 2/3Completed2016196 people29 Apr 2016clinicaltrials.gov

NCT00212342

Phase 3Completed2004100 people21 Sept 2005clinicaltrials.gov

NCT00212368

Phase 3Completed200421 Sept 2005clinicaltrials.gov